cycloheximide has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bargale, A; E, S; Kaveeshwar, V; Khode, V; Patil, S; Ruikar, K | 1 |
1 other study(ies) available for cycloheximide and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Ubiquitin Mediated Degradation of EGFR by 17 β-estradiol in Triple Negative MDA-MB-231 (TNBC) Breast Cancer Cells Line.
Topics: Cell Line, Tumor; Cell Proliferation; Cycloheximide; ErbB Receptors; Estradiol; Estrogens; Humans; Triple Negative Breast Neoplasms; Ubiquitin | 2022 |